相关实验视频

Updated: Jul 16, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

微生物衍生的胆酸甲基酸及其表基因抑制了 Clostridioides difficile 的生长和致病性,同时保护了肠道微生物群的成员

Samantha C Kisthardt¹, Rajani Thanissery¹, Colleen M Pike¹

¹Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina, USA.

Journal of bacteriology

|September 11, 2023

概括

胆酸表皮剂,隔离甲酸 (iLCA) 和隔离甲酸 (iaLCA),有效地抑制了Clostridioides difficile的生长和毒素的表达. 这些化合物显示出作为向治疗的前景,对有益的肠道微生物群的影响最小.

科学领域:

微生物学微生物学
胃肠病学胃肠病学
药理学药理学是指药理学的学科.

背景情况:

艰难结肠杆菌感染 (CDI) 是与使用抗生素破坏肠道微生物群和减少保护性胆汁酸相关的重大健康问题.
二次性胆酸,如石灰酸 (LCA) 和其表皮分离石灰酸 (iLCA),表现出对C. difficile的抑制作用.

研究的目的:

调查LCA及其表皮体 (iLCA,iaLCA) 对C. difficile的抑制机制.
评估这些胆汁酸对C. difficile生长,毒素产生和宿主细胞细胞毒性的影响.

主要方法:

最低抑制度 (MIC) 测试针对C. difficile和一个开始性肠道微生物群小组.
杀菌试验,膜损伤评估和毒素表达/活性评估.
卡科-2细胞亡和活力测试以确定宿主细胞毒性.

主要成果:

iLCA和iaLCA在体外显示出强大的抑制C. difficile的生长,节省了大多数Gram-阴性杂交体.
这些表层表现出杀菌活性,并造成了显著的细菌膜损伤.
iLCA和iALCA降低了TcdA的表达,而LCA降低了毒素的活性.

结论:

LCA 副类型 iLCA 和 iaLCA 是 C. difficile 的有效抑制剂,以不同的机制向生长和毒性因素.
这些胆汁酸代表了CDI的有希望的治疗候选者,提供了针对性的作用,对肠道微生物群的破坏最小.
需要进一步的研究,以优化这些胆汁酸的输送,用于肠道治疗应用.

关键词:

克洛斯特里迪奥伊德斯困难菌它们是表层的表层.我们的肠道微生物群.石化酸盐是什么石化酸盐是什么二次胆汁酸二次胆汁酸

更多相关视频

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Biological Methods for Microbial Control

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Methods for Controlling Microbial Growth

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...